A 25-year-old woman is newly diagnosed with type 2 diabetes after fasting plasma glucose 8.4 mmol/L on two occasions and HbA1c 8.1%. She has a BMI of 34 kg/m², no cardiovascular disease and normal renal function. According to the Diabetes Canada pharmacologic management guideline, what is the most appropriate initial pharmacologic strategy?